MONDAY, Oct. 30, 2023 (HealthDay News) — Patients with sickle cell disease may soon have two new treatments to try. On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a new gene therapy for the painful, inherited condition, which typically strikes Black people. The agencyContinue Reading

TUESDAY, Sept. 12, 2023 (HealthDay News) — It’s possible that the cause of spontaneous, recurring brain hemorrhages can be passed through blood transfusion, researchers say. The likelihood of this happening is very slim, however. Still, “blood transfusions are relatively common, which makes possible negative effects an important public health issue,”Continue Reading

FRIDAY, Sept. 8, 2023 (HealthDay News) — It’s well known that certain forms of birth control carry a small risk of blood clots. Now a large new study suggests that some common painkillers can magnify that risk. The study, of 2 million Danish women, found what numerous others have before:Continue Reading

THURSDAY, June 15, 2023 (HealthDay News) — Intermittent fasting is all the rage due to the lengthy list of health benefits associated with this style of eating. Now, a new, small study suggests that one type of intermittent fasting — early time-restricted eating — may be key for preventing typeContinue Reading

WEDNESDAY, May 31, 2023 (HealthDay News) — An exceptionally pricey gene therapy cure for sickle cell disease could soon be available, but it’s not clear whether insurance companies will balk at the cost and deny coverage. On the surface, the gene therapy does not appear as cost-effective as the grindingContinue Reading